Active Litigation
Vaginal Mesh Lawsuit Facts
TorHoerman Law is actively accepting claims for the Vaginal Mesh Lawsuit.
Active Litigation
TorHoerman Law is actively accepting claims for the Vaginal Mesh Lawsuit.
Ethicon transvaginal mesh lawsuit claims center on allegations that certain pelvic mesh devices were defectively designed and sold without adequate warnings about their risks.
Women who received these products have reported serious complications, including chronic pelvic pain, mesh erosion, infections, organ damage, and the need for multiple corrective surgeries.
TorHoerman Law is reviewing claims involving injuries allegedly linked to Ethicon and other transvaginal mesh devices.

Ethicon is one of the best-known vaginal mesh manufacturers tied to nationwide litigation over pelvic mesh implants used in women’s health procedures.
These devices were promoted as surgical mesh solutions to treat pelvic organ prolapse and stress urinary incontinence, often through placement in the vaginal canal.
In medical records, they may be described broadly as vaginal and pelvic mesh implant systems, even when the exact brand or model is not obvious to the patient.
Lawsuits involving Ethicon vaginal mesh devices generally focus on whether the product design and labeling gave a realistic picture of long-term risks once mesh is implanted into pelvic tissue.
Many women report severe complications such as mesh erosion or exposure, chronic pelvic pain, infections, urinary problems, painful intercourse, and repeat surgeries intended to revise or remove the mesh.
Those outcomes can become medically complicated because symptoms may develop gradually, and removal can involve additional procedures with no guarantee of complete relief.
Federal regulators also took steps that reshaped the market for certain transvaginal mesh products, particularly those used for transvaginal prolapse repair.
TorHoerman Law is reviewing claims from women who suffered injuries after transvaginal mesh implantation, including cases involving Ethicon devices.
If you or a loved one have suffered complications after being implanted with an Ethicon transvaginal mesh product, you may be eligible to file a lawsuit and seek financial compensation.
Contact TorHoerman Law today for a free consultation.
You can also use the chat feature on this page to find out if you qualify for an Ethicon transvaginal mesh lawsuit.
Ethicon became a central target in national litigation involving vaginal and pelvic mesh products implanted to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP).
Many of these transvaginal mesh cases focused on devices made with polypropylene mesh, which was intended to reinforce weakened pelvic support structures.
Plaintiffs in the vaginal mesh case against Ethicon commonly alleged that this material could interact poorly with vaginal tissue over time, contributing to inflammation, erosion or exposure, pain, and other complications.
Reported vaginal mesh injuries often included chronic pelvic pain, painful intercourse, infections, urinary problems, bleeding, scarring, and repeat surgeries intended to revise or remove implanted mesh.
Because symptoms can emerge gradually, many claims turned on medical documentation that showed how complications developed, how the device was identified, and what treatment was required.
Ethicon was named in federal multidistrict litigation (MDL) proceedings that coordinated many of these cases in one court for pretrial management.
That MDL is now terminated, but lawyers are still investigating individual cases against the company because the injuries and alleged failure-to-warn or design issues can remain fact-intensive long after implantation.
For many patients, the key question is whether the records show a specific Ethicon device and a complication pattern consistent with the injuries described in prior litigation.

Developments in vaginal mesh lawsuits against Ethicon:
For someone evaluating a potential claim today, the most important starting point is identifying which vaginal and pelvic mesh products were implanted and why, since SUI and POP procedures are not always discussed the same way in records.
A case review typically focuses on operative notes, implant stickers, and subsequent treatment records that document the course of symptoms and any corrective procedures.
Even without an active MDL, transvaginal mesh cases can still be pursued individually when the facts support allegations tied to a particular product, implantation history, and injury pattern.
These evaluations often center on how the mesh behaved in vaginal tissue, the seriousness of the resulting complications, and the extent of medical treatment required.
Ethicon was one of the most prominent vaginal mesh manufacturers named in nationwide litigation involving pelvic repair devices.
Claims involving Ethicon vaginal mesh devices often focus on specific product lines used in procedures for pelvic organ prolapse or stress urinary incontinence.
Patients may not recognize the product name at the time of surgery, since operative notes and billing records often use shorthand terms or brand families rather than full device identifiers.

Ethicon products commonly named in lawsuits include:
Transvaginal mesh injuries and complications are a central issue in litigation involving pelvic repair implants placed through the vagina.
Many lawsuits against transvaginal mesh manufacturers allege that certain surgical mesh devices were prone to erosion, contraction, or migration once implanted, especially in the delicate anatomy of the pelvic floor.
When mesh is implanted through or near the vaginal wall, patients may experience symptoms that worsen over time rather than resolve after recovery from mesh implant surgeries.
Some complications present as localized tissue damage, while others involve broader pelvic dysfunction that affects urination, mobility, and sexual function.
In more serious cases, the complication is not just discomfort, but severe injuries that require additional operations and long-term medical care.

Commonly reported injuries and complications include:
Mesh removal can be medically complicated because implanted material may integrate into tissue and scar planes, making complete excision difficult in some cases.
Even after revision procedures, patients may continue to deal with chronic pain or functional symptoms that require ongoing treatment.
These outcomes are why device identification and a clear timeline of symptoms and medical interventions often matter in evaluating potential claims.
Treatment for injuries linked to defective pelvic mesh and transvaginal mesh depends on the type of complication, how long the mesh has been implanted, and how the surrounding tissue has responded.
Some transvaginal mesh complications can initially be managed conservatively, but symptoms often progress when mesh has eroded into or adhered to tissue.
When mesh integrates into weakened vaginal walls, treatment becomes more complex and may require surgical intervention by specialists familiar with mesh-related injuries.
In many cases, patients undergo additional procedures following the original transvaginal mesh implant, especially when pain, erosion, or organ involvement persists.

Treatment approaches may include:
The FDA’s oversight of vaginal mesh evolved in stages, with the agency drawing sharper distinctions over time between mesh used for pelvic organ prolapse (POP) repair through the vagina and mesh used for stress urinary incontinence (SUI) procedures.
In 2008, the FDA issued a Public Health Notification about complications associated with transvaginal placement of surgical mesh for POP and SUI, then revisited the issue as adverse event reports and published data grew.
After reviewing available evidence, the FDA’s 2011 Safety Communication stated that serious complications associated with transvaginal POP mesh are not rare, and it questioned whether transvaginal POP repair with mesh improved outcomes compared to traditional non-mesh repairs in all patients.
In January 2012, the FDA ordered manufacturers to conduct 522 postmarket surveillance studies for certain urogynecologic mesh devices, including mesh used for transvaginal POP repair and mini-slings for SUI, to address specific safety and effectiveness questions.
By April 16, 2019, after reviewing premarket approval applications, the FDA ordered remaining manufacturers of transvaginal mesh for POP repair to stop selling and distributing those products in the United States.

The FDA’s stated rationale focused on the absence of evidence demonstrating a reasonable assurance of safety and effectiveness, including the agency’s view that the submitted data did not meet the evidentiary expectations discussed by an FDA advisory panel earlier that year.
The FDA has continued to address SUI slings and abdominal POP mesh procedures separately from transvaginal POP mesh kits.
These actions did not declare that every mesh implant or every patient outcome would be the same, but they did raise the bar for what manufacturers had to prove, especially for transvaginal POP mesh.
Eligibility for Ethicon transvaginal mesh litigation usually starts with proof that an Ethicon pelvic mesh device was implanted during a procedure for pelvic organ prolapse or stress urinary incontinence.
Many vaginal mesh claims also depend on documented symptoms or treatment showing that the patient experienced meaningful harm after implantation.
Common pelvic mesh complications that may support a case include mesh erosion or exposure, chronic pelvic pain, infection, urinary problems, painful intercourse, or the need for revision surgery or removal attempts.

A qualifying case typically involves a clear timeline that connects the onset or progression of symptoms to the mesh implant and subsequent medical care.
Because medical charts do not always list a brand name in plain language, operative reports, implant stickers, and revision records often become critical for confirming the product and procedure.
Prior case history matters, but each claim still turns on individual facts such as the device used, the injury pattern, and the treatment required.
Although large proceedings have ended, vaginal mesh lawsuits continue to be filed individually in appropriate courts, and case screening still focuses on evidence and deadlines.
Anyone considering vaginal mesh litigation should treat the statute of limitations as case-specific, since many states use discovery rules that can depend on when the injury was identified or reasonably linked to the mesh.
Evidence is often the difference between a vague suspicion and a viable vaginal or pelvic mesh case, because the claim usually depends on proving what device was implanted, what went wrong, and what treatment was required.
Lawyers typically start by building a complete medical timeline that connects the mesh implant to the onset of symptoms, the progression of complications, and any corrective care.
That record-building also helps frame how a case may involve alleged design and manufacturing defects, inadequate warnings, or both, depending on the product and injury pattern.
Because hospitals and surgeons do not keep every record forever, attorneys also focus on preserving time-sensitive materials, especially when a patient has undergone or may need mesh removal surgeries.
Once gathered, evidence has to be organized in a way that supports medical causation, damages, and product identification, which is why experienced case teams spend significant time on retrieval, indexing, and expert-ready documentation.

Evidence often includes:
Damages in vaginal mesh lawsuits refer to the losses a patient can document and tie to the injury, including medical, financial, and quality-of-life harms.
Vaginal mesh lawyers typically evaluate damages by collecting records, building a treatment timeline, and identifying how complications changed the person’s daily life and future care needs.
They also use billing records, expert input, and employment documentation to quantify costs that are already known and project costs that are reasonably expected.
While transvaginal mesh settlements and verdicts vary widely, damages analysis focuses on the specific facts of the case, not headline numbers from other lawsuits.
The goal is to present a grounded, evidence-based valuation that reflects the seriousness of the injury and the long-term impact on health and functioning.

Damages commonly claimed include:
TorHoerman Law is investigating claims involving Ethicon vaginal mesh devices and the serious complications some women report after transvaginal implantation.
A focused case review looks at what product was used, how symptoms developed, what treatment was required, and whether the medical record supports a clear connection between the device and the injuries.
If you are dealing with ongoing pelvic pain, erosion, infection, urinary problems, or repeat procedures after a mesh implant, a conversation with a transvaginal mesh lawyer can help clarify whether the facts support an individual lawsuit.

Contact TorHoerman Law to discuss your history and learn what records may be needed to evaluate your claim.
You can also use the chat feature on this page to find out if you qualify for an Ethicon vaginal mesh lawsuit.
Average vaginal mesh settlements are commonly discussed in a broad range because outcomes depend heavily on the device involved, the severity of the injury, and the amount of treatment required.
For many transvaginal mesh claims, a typical estimate range is about $150,000 to more than $400,000 for cases with documented complications and meaningful medical intervention, with some cases resolving for less and some for more when injuries are severe or require extensive revision care.
Settlement value usually increases when there are multiple surgeries, documented erosion or organ injury, long-term pain, and clear evidence tying the symptoms to the specific mesh product.
The most reliable way to estimate a case is to match the medical record, implant identification, and treatment history to how similar injuries have been valued in prior resolutions.
Vaginal mesh complications can manifest in various ways.
Common signs and symptoms of complications include:
If you are experiencing any of these symptoms or complications, seek immediate medical attention.
Yes. Beyond Ethicon, Boston Scientific, and American Medical Systems, several other manufacturers have been named in vaginal mesh lawsuits, and many of those cases were also coordinated in now-closed federal multidistrict litigation (MDL) proceedings.
In the Southern District of West Virginia, the court maintained separate pelvic mesh MDLs for C.R. Bard, Coloplast, Cook Medical, and Neomedic, and each of those MDLs is listed as closed/terminated.
While the MDL structure has largely wound down, this does not mean every potential claim disappeared, it mainly reflects that centralized pretrial coordination ended and remaining matters moved into other procedural tracks.
In addition, there was separate federal coordination for certain sling litigation outside West Virginia, including Mentor Worldwide LLC (ObTape) in MDL 2004 in the Middle District of Georgia.
Vaginal mesh lawsuits have been filed against:
Yes, the legal landscape remains active even though the big federal proceedings have largely ended.
Over 100,000 transvaginal mesh lawsuits have been filed on behalf of women injured by vaginal mesh and pelvic mesh products, and many women describe major financial, physical, and mental setbacks tied to long-term complications from transvaginal mesh implants.
The FDA ordered manufacturers to stop selling transvaginal mesh for pelvic organ prolapse (POP) repair in April 2019, which is often treated as a major inflection point in the litigation narrative.
Ethicon’s federal pelvic mesh docket (MDL 2327) was terminated in 2021, and reporting on the broader MDL landscape has noted that over 95% of cases were resolved or dismissed by mid-2022, with the remaining disputes moving into other tracks.
Major jury outcomes cited in public reporting include a $120 million Philadelphia verdict in an Ethicon pelvic mesh case, and a $302 million California judgment that the U.S. Supreme Court declined to review, leaving the judgment intact.
Plaintiffs have argued that while mesh devices were promoted as safe solutions for pelvic organ prolapse and stress urinary incontinence, manufacturers failed to warn about serious risks, including ongoing pelvic pain and the potential need for multiple revision procedures.
In the California enforcement case, appellate materials describe findings that Ethicon circulated marketing and instructions that misstated, minimized, or omitted health risks of its transvaginal pelvic mesh products, and the trial record includes extensive discussion of what the company knew and when.
Even with the MDLs closed, new cases continue to be filed in state courts across the country, which is why individual case review still matters.
The statute of limitations is state-specific and often depends on when the injury was discovered or reasonably linked to the device, with many sources describing a general range of about 1 to 6 years depending on jurisdiction.
The treatment for vaginal mesh complications and injuries depends on the specific difficulties you are experiencing.
Common treatments may include:
Many people only learn what was used after symptoms lead to follow-up care or a revision, and the product name may not be obvious from discharge paperwork alone.
A case review typically starts by requesting the operative report and implant documentation to identify the pelvic mesh device manufactured and confirm whether it was a mesh sling or another type of implant used for pelvic organ prolapse repair.
In some records, the procedure is described in general terms even when the implant was one of the traditional mid urethral slings, which is why the implant sticker and hospital supply log matter.
If complications are present, those records also show whether the patient needed a complex mesh surgical service for revision care or removal planning.
Once the device and treatment history are clear, lawyers can evaluate whether the facts support pelvic mesh claims.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Vaginal Mesh Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.